Literature DB >> 20504127

Effects of hyperbaric oxygenation on blood pressure levels of spontaneously hypertensive rats.

Fumiko Nagatomo1, Hidemi Fujino, Isao Takeda, Akihiko Ishihara.   

Abstract

Five-week-old normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) were subjected to hyperbaric oxygenation with an enhanced atmospheric pressure (950 mmHg) and an increased oxygen concentration (36%) for 6 h per day. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were monitored for 8 weeks of hyperbaric oxygenation period. After 8 weeks of hyperbaric oxygenation, the derivatives of reactive oxygen metabolites (dROMs) and biological antioxidant potentials (BAPs) were measured. After 5 weeks of hyperbaric oxygenation, the hyperbaric group of WKY exhibited lower SBP than the age-matched normobaric group, while there were no differences in the DBP between the normobaric and hyperbaric groups. After 3 and 7 weeks of hyperbaric oxygenation, the hyperbaric group of SHR exhibited lower SBP and DBP than the age-matched normobaric group. The hyperbaric groups of both WKY and SHR exhibited lower dROMs than the respective normobaric groups. There were no differences in BAPs between the normobaric and hyperbaric groups of WKY. In contrast, the hyperbaric group of SHR exhibited higher BAPs than the normobaric group. We conclude that the hyperbaric oxygenation conditions used in this study effectively repress hypertension.

Entities:  

Mesh:

Year:  2010        PMID: 20504127     DOI: 10.3109/10641960903254521

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  10 in total

Review 1.  Mild hyperbaric oxygen: mechanisms and effects.

Authors:  Akihiko Ishihara
Journal:  J Physiol Sci       Date:  2019-05-06       Impact factor: 2.781

2.  Effects of exposure to mild hyperbaric oxygen during unloading on muscle properties in rats.

Authors:  Akihiko Ishihara
Journal:  J Muscle Res Cell Motil       Date:  2019-07-01       Impact factor: 2.698

3.  Effects of exposure to hyperbaric oxygen on oxidative stress in rats with type II collagen-induced arthritis.

Authors:  F Nagatomo; N Gu; H Fujino; T Okiura; F Morimatsu; I Takeda; A Ishihara
Journal:  Clin Exp Med       Date:  2009-09-25       Impact factor: 3.984

4.  Mild Hyperbaric Oxygen Improves Decreased Oxidative Capacity of Spinal Motoneurons Innervating the Soleus Muscle of Rats with Type 2 Diabetes.

Authors:  Ai Takemura; Akihiko Ishihara
Journal:  Neurochem Res       Date:  2016-05-25       Impact factor: 3.996

5.  Hyperbaric oxygen exposure reduces age-related decrease in oxidative capacity of the tibialis anterior muscle in mice.

Authors:  Takahiro Nishizaka; Fumiko Nagatomo; Hidemi Fujino; Tomoko Nomura; Tomohiko Sano; Kazuhiko Higuchi; Isao Takeda; Akihiko Ishihara
Journal:  Enzyme Res       Date:  2010-01-19

6.  Unloading-induced atrophy and decreased oxidative capacity of the soleus muscle in rats are reversed by pre- and postconditioning with mild hyperbaric oxygen.

Authors:  Ai Takemura; Roland R Roy; Ikumi Yoshihara; Akihiko Ishihara
Journal:  Physiol Rep       Date:  2017-07

7.  Mild Hyperbaric Oxygen Inhibits Growth-related Decrease in Muscle Oxidative Capacity of Rats with Metabolic Syndrome.

Authors:  Ai Takemura; Akihiko Ishihara
Journal:  J Atheroscler Thromb       Date:  2016-05-26       Impact factor: 4.928

8.  Exposure to a mild hyperbaric oxygen environment elevates blood pressure.

Authors:  Ai Takemura
Journal:  J Phys Ther Sci       Date:  2022-05-01

9.  Oxygen concentration-dependent oxidative stress levels in rats.

Authors:  Fumiko Nagatomo; Hidemi Fujino; Hiroyo Kondo; Akihiko Ishihara
Journal:  Oxid Med Cell Longev       Date:  2012-09-04       Impact factor: 6.543

10.  Effects of Exposure to Mild Hyperbaric Oxygen on DSS-Induced Colonic Inflammation and Diarrhea in Rats.

Authors:  Ai Takemura; Tatsuro Egawa; Takuji Tanaka; Takashi Kuramoto; Tatsuya Hayashi; Akihiko Ishihara
Journal:  J Inflamm Res       Date:  2019-10-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.